Investigational Influenza Vaccine Clinical Trial.

This study is testing a new investigational influenza vaccine to find the safest and most effective dose for better prevention of influenza outbreaks in healthy adults aged 18-49.

This study is being conducted at our Canberra and Brisbane Clinics.

Chlamydia Vaccine Clinical Trial.

This clinical trial is assessing whether an investigational vaccine can safely and effectively prevent chlamydia infections among young adults.

The study is being conducted at our Brisbane and Canberra clinics.

Apply Now

Flu Vaccine Clinical Trial for Adults 65+

This 8-month study is evaluating two already approved flu vaccines to determine which one provides better protection against influenza in adults aged 65 and over.

This study is being conducted at our Central Coast, Western Sydney and Brisbane clinics.

A clinical trial of an investigational norovirus vaccine for adults

This study is researching whether an investigational vaccine is safe, well-tolerated and is able to protect against norovirus gastroenteritis, a virus that can cause gastro.

This study is being conducted at our Brisbane, Central Coast and Canberra sites.

Help Us Study Potential Vaccines for Flu, RSV, hMPV, and PIV3: A Research Opportunity for Adults 18–49.

Paratus Clinical are conducting a trial evaluating new potential vaccines for respiratory illnesses like the flu, RSV, hMPV, and PIV3. If you’re aged 18 to 49 and healthy, you may be eligible to participate in this 6-month study. Reimbursement will be provided for participation.

This study is being conducted at our Western Sydney and Brisbane clinics.